Filing Details
- Accession Number:
- 0001225208-11-004882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-07 16:15:46
- Reporting Period:
- 2011-02-03
- Filing Date:
- 2011-02-07
- Accepted Time:
- 2011-02-07 16:15:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403373 | A John Deford | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Sr. Vp Sci Tech And Clin Afrs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-03 | 11,000 | $66.80 | 48,104 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-02-03 | 10,425 | $73.99 | 58,529 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-03 | 21,425 | $93.08 | 37,104 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2011-02-03 | 10,425 | $0.00 | 10,425 | $73.99 |
| Common Stock | Option (Right to Buy) | Disposition | 2011-02-03 | 11,000 | $0.00 | 11,000 | $66.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-07-12 | No | 4 | M | Direct | |
| 0 | 2015-07-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 442 | Indirect | 401(k) Plan |
Footnotes
- Includes 1.2835 shares acquired under the Company's Employee Stock Purchase Plan from August 6, 2010 to February 4, 2011.
- Represents the weighted average sales price for price increments ranging from $93.05 to $93.26. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Options vest in accordance with schedule upon achievement of certain performance criteria or fully vest in five years.
Billionaire Hedge Funds
